Avidian Wealth Solutions, LLC Gilead Sciences, Inc. Transaction History

Avidian Wealth Solutions, LLC

$2.13 Billion
Q3 2024

A detailed history of Avidian Wealth Solutions, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Avidian Wealth Solutions, LLC holds 8,612 shares of GILD stock, worth $786,706. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,612

Previous 8,302 3.73%

Holding current value

$786,706

Previous $569,000 26.71%

% of portfolio

0.03%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$66.59 - $83.99 $20,642 - $26,036	310 Added 3.73%	8,612 $721,000
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $98,577 - $113,765	1,561 Added 23.16%	8,302 $569,000
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $100,713 - $122,817	-1,407 Reduced 17.27%	6,741 $493,000
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $18,976 - $21,520	259 Added 3.28%	8,148 $660,000
Q3 2023 Oct 13, 2023	SELL	$73.94 - $80.67 $15,083 - $16,456	-204 Reduced 2.52%	7,889 $591,000
Q2 2023 Aug 03, 2023	SELL	$76.01 - $86.7 $142,518 - $162,562	-1,875 Reduced 18.81%	8,093 $623,000
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $618 - $704	-8 Reduced 0.08%	9,968 $827,000
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $25,987 - $37,308	417 Added 4.36%	9,976 $856,000
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $92,227 - $105,347	-1,549 Reduced 13.94%	9,559 $590,000
Q2 2022 Jul 29, 2022	BUY	$57.72 - $65.01 $65,916 - $74,241	1,142 Added 11.46%	11,108 $687,000
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $40,949 - $51,314	707 Added 7.64%	9,966 $593,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $973 - $1,104	15 Added 0.16%	9,259 $672,000
Q3 2021 Nov 10, 2021	BUY	$67.69 - $73.03 $42,712 - $46,081	631 Added 7.33%	9,244 $646,000
Q2 2021 Aug 09, 2021	SELL	$63.47 - $69.35 $8,695 - $9,500	-137 Reduced 1.57%	8,613 $593,000
Q1 2021 May 05, 2021	SELL	$60.0 - $68.46 $42,060 - $47,990	-701 Reduced 7.42%	8,750 $566,000
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $24,076 - $27,433	425 Added 4.71%	9,451 $551,000
Q3 2020 Feb 03, 2021	BUY	$62.1 - $78.08 $560,514 - $704,750	9,026 New	9,026 $570,000
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $355,646 - $447,164	-5,727 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $86,735 - $100,716	1,199 Added 26.48%	5,727 $441,000
Q1 2020 Apr 22, 2020	BUY	$62.63 - $80.22 $1,315 - $1,684	21 Added 0.47%	4,528 $339,000
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $184 - $203	-3 Reduced 0.07%	4,507 $293,000
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $19,003 - $20,976	304 Added 7.23%	4,510 $286,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $63,416 - $71,114	1,025 Added 32.22%	4,206 $284,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $198,907 - $222,829	3,181 New	3,181 $207,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.

Account

Avidian Wealth Solutions, LLC Gilead Sciences, Inc. Transaction History